Charles Mosseri - Oct 23, 2025 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
10%+ Owner
Signature
/s/ Charles Mosseri-Marlio
Stock symbol
NVCT
Transactions as of
Oct 23, 2025
Transactions value $
$957,083
Form type
4
Date filed
10/29/2025, 08:00 AM
Previous filing
Jun 24, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mosseri Marlio Charles 10%+ Owner 27 RIPPLEVALE GROVE, LONDON, LIBYAN ARAB JAMAHIRIYA /s/ Charles Mosseri-Marlio 2025-10-29 0001806384

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $284K +46.9K +1.57% $6.06 3.03M Oct 23, 2025 By Emerald Hill Ventures SARL SPF. F1
transaction NVCT Common Stock Purchase $215K +35K +1.16% $6.15 3.06M Oct 24, 2025 By Emerald Hill Ventures SARL SPF. F1
transaction NVCT Common Stock Purchase $457K +72.8K +2.38% $6.28 3.14M Oct 27, 2025 By Emerald Hill Ventures SARL SPF. F1
holding NVCT Common Stock 109K Oct 23, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF.